PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1782000
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1782000
Biosimilar and Biologics Market, By Product Type, By Application, By Distribution, By Manufacturing Type, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
REPORT HIGHLIGHT
Biosimilar and Biologics Market size was valued at US$ 556,309.44 Million in 2024, expanding at a CAGR of 7.81% from 2025 to 2032.
The biosimilars and biologics market represents one of the fastest-growing sectors in the global pharmaceutical industry. Biologics are large, complex molecules or mixtures of molecules derived from living cells used in the treatment, diagnosis, or prevention of diseases. Examples include monoclonal antibodies, vaccines, and recombinant proteins. Fueled by advances in biotechnology, rising prevalence of chronic diseases, patent expirations of blockbuster biologics, and increasing healthcare costs, the market is witnessing rapid transformation.
Biosimilar and Biologics Market- Market Dynamics
Patent Expiration of Blockbuster Biologics
One of the most significant growth drivers in the biosimilars market is the expiration of patents for major biologic drugs. These biologics, often called "blockbusters", generate billions in annual sales. When their patents expire, it opens the door for biosimilar manufacturers to develop and market more affordable alternatives. For instance, Adalimumab (Humira), one of the world's top-selling biologics used to treat rheumatoid arthritis and Crohn's disease, generated over $20 billion/year in revenue before biosimilars entered the market. The expiration of patents on blockbuster biologics is a fundamental driver of growth in the biosimilar market. It enables competition, reduces drug prices, and expands access to biologic therapies-ultimately creating a more sustainable global healthcare system. This trend will continue over the next decade as more biologics lose exclusivity, paving the way for a surge in biosimilar development and adoption.
Biosimilar and Biologics Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.81% over the forecast period (2025-2032)
Based on product type segmentation, Biologics was predicted to show maximum market share in the year 2024
Based on application segmentation, Oncology was the leading application in 2024
Based on distribution segmentation, Hospital Pharmacies was the leading distribution in 2024
On the basis of region, North America was the leading revenue generator in 2024
Biosimilar and Biologics Market- Segmentation Analysis:
The Global Biosimilar and Biologics Market is segmented on the basis of Product Type, Application, Distribution, Manufacturing Type, and Region.
The market is divided into two categories based on product type: Biologics, and Biosimilars. Biologics and Biosimilars. Biologics are original, complex medicines made from living organisms, used to treat diseases like cancer and autoimmune disorders. Biosimilars are highly similar, lower-cost versions of approved biologics, developed after the original product's patent expires, offering comparable safety and effectiveness.
The market is divided into two categories based on application: Oncology, Infectious Diseases, Autoimmune Diseases (e.g., rheumatoid arthritis, psoriasis), Blood Disorders (e.g., anemia, hemophilia), Diabetes, Growth Hormone Deficiency, Ophthalmic Disorders (e.g., macular degeneration) and Others (e.g., rare diseases, fertility treatments). Cancer is one of the leading causes of death globally, with a rising incidence due to aging populations, lifestyle changes, and improved diagnostics. Biologics particularly monoclonal antibodies and targeted therapies-have revolutionized cancer treatment by offering personalized, effective solutions with fewer side effects compared to traditional chemotherapy. Additionally, oncology accounts for a large share of R&D investments, clinical trials, and regulatory approvals in both biologics and biosimilars, reinforcing its dominance. With cancer cases projected to rise and the focus on precision medicine growing, oncology will likely remain the most demanding and profitable application area in this market.
Biosimilar and Biologics Market- Geographical Insights
The biosimilar and biologics market shows varying growth patterns across different geographical regions. North America, particularly the United States, holds a major share in the biologics market due to advanced healthcare infrastructure, strong R&D investments, and the presence of key pharmaceutical players. Although biosimilar adoption was initially slow in the U.S. due to regulatory and market barriers, it is now accelerating following the expiration of patents for blockbuster drugs like Humira. Europe is the most mature and established market for biosimilars, driven by cost-containment policies, supportive regulatory frameworks by the European Medicines Agency (EMA), and high physician and patient acceptance. Asia-Pacific is the fastest-growing region, with countries like India, China, and South Korea emerging as major biosimilar manufacturers. This growth is supported by large patient populations, increasing healthcare access, and improving regulatory pathways. In Latin America, the market is expanding steadily as countries modernize their healthcare systems and encourage biosimilar use to reduce public spending. Lastly, the Middle East and Africa represent emerging markets with growing demand for affordable biologic treatments, although access and infrastructure challenges remain. Overall, while Europe leads in biosimilar adoption, North America and Asia-Pacific are set to drive future market growth.
Biosimilar and Biologics Market- Competitive Landscape:
The competitive landscape of the biosimilars and biologics market is characterized by intense rivalry among a mix of established pharmaceutical giants and emerging biotech companies. Major players like Amgen, Pfizer, Roche, Novartis (Sandoz), Samsung Bioepis, Biocon, Celltrion, and Mylan (Viatris) dominate the market, leveraging strong R&D capabilities, extensive manufacturing facilities, and global distribution networks to maintain and expand their market share. These companies are investing heavily in developing biosimilars for high-demand biologics whose patents have expired or are nearing expiration. Competition is not only based on pricing but also on product quality, regulatory approvals, patent strategies, and marketing efforts to build physician and patient trust. Additionally, strategic partnerships, collaborations, and mergers and acquisitions are common to enhance pipeline portfolios and access new markets. The landscape is further complicated by regional differences in regulatory requirements and market access, which influence how companies position their biosimilar products worldwide. As the market evolves, innovation in bioprocessing technologies and tailored therapies will be crucial for companies aiming to stay competitive in this rapidly growing sector.
Recent Developments:
In March 2025, Fresenius Kabi received U.S. FDA approval for two of their denosumab biosimilars, Conexxence and Bomyntra, which are now approved for the same indications as the original reference drugs, Prolia and Xgeva, respectively. This approval enhances treatment options for patients with osteoporosis and cancer-related bone loss, contributing to the growing acceptance of biosimilars in the U.S. market .
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BIOSIMILAR AND BIOLOGICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Amgen Inc.
- Novartis AG (Sandoz)
- Pfizer Inc.
- Roche Holding AG
- Samsung Bioepis
- Biocon Ltd.
- Mylan N.V. (Viatris)
- Celltrion Inc.
- Fresenius Kabi
- Boehringer Ingelheim
- Cipla Limited
- Teva Pharmaceutical Industries Ltd.
- Sandoz (a Novartis division)
- Dr. Reddy's Laboratories
- Intas Pharmaceuticals Ltd.
- Zhejiang Hisun Pharmaceutical Co., Ltd.
- LG Chem Life Sciences
- Pfizer Inc.
- Hetero Drugs Limited
- Oncobiologics, Inc.
- Others
GLOBAL BIOSIMILAR AND BIOLOGICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
Biologics:
- Monoclonal Antibodies (mAbs)
- Vaccines
- Recombinant Hormones (e.g., insulin, human growth hormone)
- Therapeutic Proteins (e.g., erythropoietin, interferons)
- Blood Products
- Gene Therapy
- Cell Therapy
Biosimilars:
- Monoclonal Antibodies Biosimilars
- Recombinant Hormones Biosimilars (e.g., insulin, growth hormone)
- Erythropoietin Biosimilars
- Filgrastim and Pegfilgrastim Biosimilars
- Infliximab, Adalimumab, Trastuzumab Biosimilars
- Interferons Biosimilars
GLOBAL BIOSIMILAR AND BIOLOGICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Oncology
- Infectious Diseases
- Autoimmune Diseases (e.g., rheumatoid arthritis, psoriasis)
- Blood Disorders (e.g., anemia, hemophilia)
- Diabetes
- Growth Hormone Deficiency
- Ophthalmic Disorders (e.g., macular degeneration)
- Others (e.g., rare diseases, fertility treatments)
GLOBAL BIOSIMILAR AND BIOLOGICS MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2019 - 2032
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
GLOBAL BIOSIMILAR AND BIOLOGICS MARKET, BY MANUFACTURING TYPE- MARKET ANALYSIS, 2019 - 2032
- In-house Manufacturing
- Contract Manufacturing Organizations (CMOs)
GLOBAL BIOSIMILAR AND BIOLOGICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Biosimilar and Biologics Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Biosimilar and Biologics Market Snippet by Product Type
- 2.1.2. Biosimilar and Biologics Market Snippet by Application
- 2.1.3. Biosimilar and Biologics Market Snippet by Distribution
- 2.1.4. Biosimilar and Biologics Market Snippet by Manufacturing Type
- 2.1.5. Biosimilar and Biologics Market Snippet by Country
- 2.1.6. Biosimilar and Biologics Market Snippet by Region
- 2.2. Competitive Insights
3. Biosimilar and Biologics Key Market Trends
- 3.1. Biosimilar and Biologics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Biosimilar and Biologics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Biosimilar and Biologics Market Opportunities
- 3.4. Biosimilar and Biologics Market Future Trends
4. Biosimilar and Biologics Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Biosimilar and Biologics Market: Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
6. Biosimilar and Biologics Market Landscape
- 6.1. Biosimilar and Biologics Market Share Analysis, 2024
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Biosimilar and Biologics Market - By Product Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
- 7.1.2. Biologics:
- 7.1.2.1. Monoclonal Antibodies (mAbs)
- 7.1.2.2. Vaccines
- 7.1.2.3. Recombinant Hormones (e.g., insulin, human growth hormone)
- 7.1.2.4. Therapeutic Proteins (e.g., erythropoietin, interferons)
- 7.1.2.5. Blood Products
- 7.1.2.6. Gene Therapy
- 7.1.2.7. Cell Therapy
- 7.1.3. Biosimilars:
- 7.1.3.1. Monoclonal Antibodies Biosimilars
- 7.1.3.2. Recombinant Hormones Biosimilars (e.g., insulin, growth hormone)
- 7.1.3.3. Erythropoietin Biosimilars
- 7.1.3.4. Filgrastim and Pegfilgrastim Biosimilars
- 7.1.3.5. Infliximab, Adalimumab, Trastuzumab Biosimilars
- 7.1.3.6. Interferons Biosimilars
8. Biosimilar and Biologics Market - By Application
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 8.1.2. Oncology
- 8.1.3. Infectious Diseases
- 8.1.4. Autoimmune Diseases (e.g., rheumatoid arthritis, psoriasis)
- 8.1.5. Blood Disorders (e.g., anemia, hemophilia)
- 8.1.6. Diabetes
- 8.1.7. Growth Hormone Deficiency
- 8.1.8. Ophthalmic Disorders (e.g., macular degeneration)
- 8.1.9. Others (e.g., rare diseases, fertility treatments)
9. Biosimilar and Biologics Market - By Distribution
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Distribution, 2024 & 2032 (%)
- 9.1.2. Hospital Pharmacies
- 9.1.3. Online Pharmacies
- 9.1.4. Retail Pharmacies
10. Biosimilar and Biologics Market - By Manufacturing Type
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By Manufacturing Type, 2024 & 2032 (%)
- 10.1.2. In-house Manufacturing
- 10.1.3. Contract Manufacturing Organizations (CMOs)
11. Biosimilar and Biologics Market- By Geography
- 11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
- 11.2. North America
- 11.2.1. Overview
- 11.2.2. Biosimilar and Biologics Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
- 11.2.8.1. Overview
- 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.8.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.8.5. U.S. Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.2.8.6. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
- 11.2.9.1. Overview
- 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.9.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.9.5. Canada Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.2.9.6. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3. Europe
- 11.3.1. Overview
- 11.3.2. Biosimilar and Biologics Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
- 11.3.8.1. Overview
- 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.8.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.8.5. Germany Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.3.8.6. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.9. UK
- 11.3.9.1. Overview
- 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.9.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.9.5. UK Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.3.9.6. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.10. France
- 11.3.10.1. Overview
- 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.10.5. France Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.3.10.6. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.11. Italy
- 11.3.11.1. Overview
- 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.11.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.11.5. Italy Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.3.11.6. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.12. Spain
- 11.3.12.1. Overview
- 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.12.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.12.5. Spain Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.3.12.6. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.13. The Netherlands
- 11.3.13.1. Overview
- 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.13.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.13.5. The Netherlands Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.3.13.6. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
- 11.3.14.1. Overview
- 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.14.5. Sweden Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.3.14.6. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.15. Russia
- 11.3.15.1. Overview
- 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.15.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.15.5. Russia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.3.15.6. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.16. Poland
- 11.3.16.1. Overview
- 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.16.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.16.5. Poland Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.3.16.6. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.17. Rest of Europe
- 11.3.17.1. Overview
- 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.17.5. Rest of the Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.3.17.6. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Biosimilar and Biologics Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.8. China
- 11.4.8.1. Overview
- 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.8.5. China Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.4.8.6. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.9. India
- 11.4.9.1. Overview
- 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.9.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.9.5. India Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.4.9.6. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
- 11.4.10.1. Overview
- 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.10.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.10.5. Japan Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.4.10.6. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
- 11.4.11.1. Overview
- 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.11.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.11.5. South Korea Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.4.11.6. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
- 11.4.12.1. Overview
- 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.12.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.12.5. Australia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.4.12.6. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.13. Indonesia
- 11.4.13.1. Overview
- 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.13.5. Indonesia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.4.13.6. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.14. Thailand
- 11.4.14.1. Overview
- 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.14.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.14.5. Thailand Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.4.14.6. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
- 11.4.15.1. Overview
- 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.15.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.15.5. Philippines Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.4.15.6. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
- 11.4.16.1. Overview
- 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.16.5. Rest of APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.4.16.6. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Biosimilar and Biologics Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
- 11.5.8.1. Overview
- 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.8.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.8.5. Brazil Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.5.8.6. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
- 11.5.9.1. Overview
- 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.9.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.9.5. Mexico Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.5.9.6. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
- 11.5.10.1. Overview
- 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.10.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.10.5. Argentina Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.5.10.6. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
- 11.5.11.1. Overview
- 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.11.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.11.5. Colombia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.5.11.6. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
- 11.5.12.1. Overview
- 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.12.5. Rest of LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.5.12.6. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Biosimilar and Biologics Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
- 11.6.8.1. Overview
- 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.8.5. Saudi Arabia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.6.8.6. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
- 11.6.9.1. Overview
- 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.9.5. United Arab Emirates Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.6.9.6. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
- 11.6.10.1. Overview
- 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.10.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.10.5. Israel Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.6.10.6. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
- 11.6.11.1. Overview
- 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.11.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.11.5. Turkey Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.6.11.6. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
- 11.6.12.1. Overview
- 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.12.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.12.5. Algeria Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.6.12.6. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
- 11.6.13.1. Overview
- 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.13.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.13.5. Egypt Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.6.13.6. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
- 11.6.14.1. Overview
- 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.14.5. Rest of MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.6.14.6. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Biosimilar and Biologics Industry
- 12.1. Competitive Dashboard
- 12.1.1. Competitive Benchmarking
- 12.1.2. Competitive Positioning
- 12.2. Company Profiles
- 12.2.1. Amgen Inc.
- 12.2.2. Novartis AG (Sandoz)
- 12.2.3. Pfizer Inc.
- 12.2.4. Roche Holding AG
- 12.2.5. Samsung Bioepis
- 12.2.6. Biocon Ltd.
- 12.2.7. Mylan N.V. (Viatris)
- 12.2.8. Celltrion Inc.
- 12.2.9. Fresenius Kabi
- 12.2.10. Boehringer Ingelheim
- 12.2.11. Cipla Limited
- 12.2.12. Teva Pharmaceutical Industries Ltd.
- 12.2.13. Sandoz (a Novartis division)
- 12.2.14. Dr. Reddy's Laboratories
- 12.2.15. Intas Pharmaceuticals Ltd.
- 12.2.16. Zhejiang Hisun Pharmaceutical Co., Ltd.
- 12.2.17. LG Chem Life Sciences
- 12.2.18. Pfizer Inc.
- 12.2.19. Hetero Drugs Limited
- 12.2.20. Oncobiologics, Inc.
- 12.2.21. Others
13. 360 Degree AnalystView
14. Appendix
- 14.1. Research Methodology
- 14.2. References
- 14.3. Abbreviations
- 14.4. Disclaimer
- 14.5. Contact Us
